Aluda Pharmaceuticals announces peer-reviewed publication on ALD-R491, an Exosome Release Inhibitor and novel oncology mechanism
Biospace,
- Tumors use exosomes to send signals to protect the tumor, promote cancer - Exosome inhibition is a new anti-cancer class…